NET LOSS PER SHARE (Details) - Schedule of dilutive shares - shares	3 Months Ended
Mar. 31, 2021	Mar. 31, 2020
Anti-dilutive shares	82,926,574	46,235,895
Convertible debt [Member]
Anti-dilutive shares	8,993,106	44,283,120
Stock options [Member]
Anti-dilutive shares	516,666	100,000
Warrants to purchase shares of common stock [Member]
Anti-dilutive shares	73,416,802	1,852,775

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration